Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 295 | 271 | 217 | 347 | 678 |
| Operating Income | -295 | -271 | -217 | -347 | -678 |
| Other Income | 7 | 2 | 45 | 28 | 195 |
| Pre-tax Income | -288 | -269 | -172 | -319 | -483 |
| Net Income Continuous | -288 | -269 | -172 | -319 | -483 |
| Net Income | $-288 | $-269 | $-172 | $-319 | $-483 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.15 | 0.00 | -0.16 |
| EPS Basic Continuous Ops | -0.05 | -0.06 | -0.04 | -0.08 | -0.11 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.15 | 0.00 | -0.16 |
| EPS Diluted Continuous Ops | -0.05 | -0.06 | -0.04 | -0.08 | -0.11 |
| EBITDA(a) | $-295 | $-271 | $-217 | $-347 | $-678 |